ArticleLeukemia2017
Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation.
Abstract readLetterComment
In one paragraph
Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.
0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 92 citations in OpenAlex.
- Outcomes of germ line testing for children with hematologic malignancies undergoing hematopoietic cell transplantation.Blood advances · 2026Article
- Germline DDX41 mutations in myeloid neoplasms: a comprehensive review.The Korean journal of internal medicine · 2026Review
- Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets.Leukemia · 2026Article
- MDS/AML-associated DDX41 helicase facilitates homologous recombination repair by potentially resolving R-loops.Nucleic acids research · 2026Article
- Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies.Cancers · 2026Review
- Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.Blood advances · 2025Article
- Detecting likely germline variants during tumor-based molecular profiling.The Journal of clinical investigation · 2025Review
- Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding.Current opinion in hematology · 2025Review
- A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation.Oncotarget · 2025Article
- Allogeneic Transplantation for Older Adults.Advances in experimental medicine and biology · 2025Review
- Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood.Annals of hematology · 2024Article
- How to manage patients with germlineHemaSphere · 2024Article
- Review
- Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.JCO precision oncology · 2024Article
- Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.International journal of hematology · 2024Review
- Genomic testing for germline predisposition to hematologic malignancies.Blood research · 2024Review
- Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.Transplantation and cellular therapy · 2024Review
- Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.Best practice & research. Clinical haematology · 2024Review
- DDX41: exploring the roles of a versatile helicase.Biochemical Society transactions · 2024Review
- Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.International journal of molecular sciences · 2024Review
Corrections and comments
- Comment on
Authors and funding
18 authors at 2 institutions in 1 country.
S KobayashiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
A KobayashiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Y OsawaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
S NagaoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
K TakanoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Y OkadaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
N TachiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
M TeramotoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T KawamuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T HoriuchiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
S KatoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T MaekawaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T YamamuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
J WatanabeDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Y HaradaDepartment of Hematology, Juntendo University, School of Medicine, Tokyo, Japan.
H HaradaDepartment of Hematology, Juntendo University, School of Medicine, Tokyo, Japan.
K SatoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
F KimuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
National Defense Medical College · JPJuntendo University · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hematopoietic Stem Cell TransplantationTissue DonorsDEAD-box RNA HelicasesHumansLeukemiaMutationDDX41 protein, humanDEAD-box RNA Helicases
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.